Streetbeat News

Revenues

NREF

NexPoint Real Estate (NYSE:NREF) reported Q3 2024 earnings per share of $0.75, surpassing the analyst estimate of $0.48, marking a 74.42% increase from the previous year. However, sales of $12.518M fell short of the $18.837M estimate, despite a 159.87% increase from last year.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 12:20 pm

LDOS

Leidos has been awarded a $235 million contract by the U.S. Department of Health and Human Services to modernize the Organ Procurement and Transplant Network. The contract includes a base period of one year and four one-year option periods.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 12:17 pm

ARW

Arrow Electronics has provided a Q4 2024 outlook with adjusted EPS expected to be between $2.48 and $2.68, below the estimated $3.42. Sales are projected to be between $6.67 billion and $7.27 billion, slightly below the $7.25 billion estimate. The company anticipates a net income per share of $1.35 to $1.55 and a non-GAAP net income per share of $2.48 to $2.68. Foreign currency changes are expected to increase sales by $60 million and EPS by $0.02 compared to Q4 2023.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 12:16 pm

K

Kellanova reported Q3 2024 earnings per share of $0.91, surpassing the analyst estimate of $0.85. The company's sales were $3.233 billion, exceeding the expected $3.158 billion. However, sales decreased by 17.92% compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 12:12 pm

EBAY

eBay shares are experiencing a decline as the company released Q4 and FY24 revenue guidance that falls short of market expectations.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 12:12 pm

LPCN

Lipocine Inc. has entered into a distribution and license agreement with SPC Korea to commercialize TLANDO in South Korea. Lipocine will receive upfront, regulatory, and sales milestone payments, as well as royalties on net sales.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 12:12 pm

FLGT

Fulgent Genetics has been awarded a five-year contract worth up to $99 million by the U.S. Department of Veterans Affairs to provide genetic testing services, including hereditary cancer and pharmacogenetic testing, to veterans.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 12:11 pm

UNIT

Uniti Group has adjusted its FY2024 financial guidance, lowering its Funds From Operations (FFO) forecast while slightly raising its sales outlook. The FFO guidance is now set at $1.23-$1.30, down from $1.33-$1.40, and below the $1.35 analyst estimate. Meanwhile, sales guidance has been increased to $1.16B-$1.18B, slightly above the previous range and the $1.17B estimate.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 12:07 pm

RBLX

Roblox has raised its FY24 booking outlook to $4.34B-$4.37B, surpassing the previous estimate of $4.23B. The revenue outlook is set between $3.55B and $3.57B. Despite a projected net loss, the company expects positive free cash flow.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 12:07 pm

BGC

BGC Group has projected its Q4 sales to be between $545 million and $595 million, surpassing the market estimate of $538.90 million.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 12:07 pm